| Ticker | AZN |
|---|---|
| ISIN | GB0009895292 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - General |
| Mercado | Londres |
| Capitalización | S/289,406,910,339 |
| Beta | 0,28 |
| Último dividendo | US$ 3,2000 |
| Sitio web | https://www.astrazeneca.com |
| CEO | Pascal Claude Roland Soriot |
| Fecha de IPO | 12/05/1993 |
| País | GB |
| Dirección | 1 Francis Crick Avenue, Cambridge, CB2 0AA |
| Volumen | 2.834.389 |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its...
Astrazeneca opera en el sector Healthcare, industria Drug Manufacturers - General.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones